##gff-version 3
##sequence-region P53805 1 252
P53805	UniProtKB	Chain	1	252	.	.	.	ID=PRO_0000211414;Note=Calcipressin-1	
P53805	UniProtKB	Compositional bias	221	229	.	.	.	Note=Poly-Glu	
P53805	UniProtKB	Modified residue	163	163	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12809556;Dbxref=PMID:12809556	
P53805	UniProtKB	Modified residue	167	167	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12809556;Dbxref=PMID:12809556	
P53805	UniProtKB	Modified residue	218	218	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9JHG6	
P53805	UniProtKB	Alternative sequence	1	135	.	.	.	ID=VSP_001316;Note=In isoform 4. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:8595418,ECO:0000303|PubMed:9325060;Dbxref=PMID:8595418,PMID:9325060	
P53805	UniProtKB	Alternative sequence	1	84	.	.	.	ID=VSP_001315;Note=In isoform 3. MEDGVAGPQLGAAAEAAEAAEARARPGVTLRPFAPLSGAAEADEGGGDWSFIDCEMEEVDLQDLPSATIACHLDPRVFVDGLCR->MVY;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:8595418,ECO:0000303|Ref.4,ECO:0000303|Ref.6;Dbxref=PMID:8595418	
P53805	UniProtKB	Alternative sequence	1	83	.	.	.	ID=VSP_001314;Note=In isoform 2. MEDGVAGPQLGAAAEAAEAAEARARPGVTLRPFAPLSGAAEADEGGGDWSFIDCEMEEVDLQDLPSATIACHLDPRVFVDGLC->MHFRNFNYSFSSLIACVANSDIFSESET;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:9325060;Dbxref=PMID:9325060	
P53805	UniProtKB	Mutagenesis	163	163	.	.	.	Note=Loss of phosphorylation%2C no loss of interaction with PPP3CA and PPP3R1%2C reduced ability to inhibit calcineurin and increased protein half-life%3B alone or when associated with A-167. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12809556;Dbxref=PMID:12809556	
P53805	UniProtKB	Mutagenesis	163	163	.	.	.	Note=No loss of phosphorylation and no effect on protein half-life%3B alone or when associated with E-167. S->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12809556;Dbxref=PMID:12809556	
P53805	UniProtKB	Mutagenesis	167	167	.	.	.	Note=Loss of phosphorylation%2C no loss of interaction with PPP3CA and PPP3R1%2C reduced ability to inhibit calcineurin and increased protein half-life%3B alone or when associated with A-163. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12809556;Dbxref=PMID:12809556	
P53805	UniProtKB	Mutagenesis	167	167	.	.	.	Note=No loss of phosphorylation and no effect on protein half-life%3B alone or when associated with E-163. S->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12809556;Dbxref=PMID:12809556	
P53805	UniProtKB	Sequence conflict	202	202	.	.	.	Note=H->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P53805	UniProtKB	Sequence conflict	214	214	.	.	.	Note=H->Q;Ontology_term=ECO:0000305;evidence=ECO:0000305	
